RXRX
Recursion Pharmaceuticals Inc
3.80$
+8.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.3% | 89.2% | 87.6% | 81.3% | 67.0% | 49.3% | 55.1% | |
| 68.9% | 87.8% | 46.7% | 78.4% | 59.9% | 41.0% | 50.4% | |
| 68.9% | 87.8% | 84.6% | 78.4% | 59.9% | 41.0% | 50.4% | |
| 0.1% | 0.1% | 1.5% | 0.4% | 0.5% | 3.4% | 1.7% | |
| 5.2% | 1.7% | 0.3% | 0.2% | -0.5% | – | – | |
| 24.0% | 8.7% | 10.6% | 17.3% | – | – | – | |
| – | 0.3% | 0.1% | 0.1% | 8.0% | 10.3% | 11.0% | |
| – | 0.6% | 0.2% | 0.2% | 5.6% | 23.2% | 21.0% | |
| 222.5% | 169.1% | 11.0% | 30.7% | 29.1% | 28.6% | 23.3% | |
| 6.6% | 7.7% | 7.6% | 14.3% | 14.3% | 12.9% | 10.0% | |
| 0.5% | 0.5% | 0.2% | 0.9% | 0.9% | 1.5% | 1.5% | |
| 1.2% | 0.4% | 0.5% | 0.7% | 0.6% | 1.5% | 1.2% | |
| 12.2% | 3.8% | 0.1% | 0.1% | 0.2% | 1.3% | 0.6% | |
| -122.5% | -69.1% | 89.0% | 69.3% | 70.9% | 71.4% | 76.7% | |
| -124.8% | -71.5% | -65.5% | -91.2% | -148.0% | -98.8% | -140.8% | |
| 163.5% | 55.5% | 27.9% | 25.0% | 31.8% | 18.9% | 30.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.